MedPath

Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient

Not Applicable
Active, not recruiting
Conditions
Carpal Tunnel Syndrome
Registration Number
NCT06905769
Lead Sponsor
Superior University
Brief Summary

Carpal Tunnel Syndrome (CTS) is a common neurological disorder due to entrapment of median nerve which runs from the forearm into the hand through a tunnel, compressed or pinched due to anatomical factors, such as a narrow carpal tunnel. Widespread condition that affects 3-6% of the general population worldwide. Carpal Tunnel Syndrome (CTS) a prevalent and debilitating condition leading to disability despite optimal interventions to rehabilitation that aimed to reducing pain and improving neural function status in Carpal Tunnel Syndrome Patients .

Detailed Description

This study investigates the additional benefits of Aquatic Therapy and Neuro-dynamic Technique in Carpal Tunnel Syndrome Patients .The researcher employs a randomized controlled trial methodology. Participants are divided into two groups: one receiving Aquatic Therapy, and the other receiving Neuro-dynamic Technique.

Outcomes are assessed over an 8-week period, focusing on pain levels and neural function restoration and grip strength. The significance of this study lies in its potential to enhance current treatment protocols, offering a more effective, intervention to alleviate symptoms and improve the quality of life, neural restoration for those suffering Carpal Tunnel Syndrome (CTS).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Diagnosed with mild-to-moderate carpal tunnel syndrome by Neuromuscular Physician
  • Participants who presented with unilateral CTS with symptoms reported up to 3 months
  • Male and female
  • Aged 18 years or older
Exclusion Criteria
  • Patients with non-specified stage of CTS,median nerve entrapment in TOS, Cervical Radiculpathy
  • Participants presents with co-morbidities,Hx of CTS (e.g., pregnancy, diabetes, trauma, congenital disorders, obesity, post-surgical release, and hypothyroidism)
  • Cardiovascular disease, thenar muscle atropy"

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
NUMERIC PAIN RATING SCALE (NPRS)12 Months

The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing "pain as bad as you can imagine" or "worst pain imaginable". The NPRS is a valid and reliable scale to measure pain intensity. NPRS demonstrates strong correlation validity with other established pain measurement scales, making it a reliable tool for clinical assessments.

Boston Carpal Tunnel Questionnaire (BCTQ)12 Months

The questionnaire has been designed to evaluate Assess the severity of CTS symptoms and functional impairment. The total number of questions is 19, total score is 95(sum of 2 subscales) in the BCTQ. Symptom Severity Scale (SSS): 11 items assessing the severity of CTS symptoms, such as numbness, tingling, and pain. Functional Status Scale (FSS) 8 items evaluating the impact of CTS on daily activities, such as grasping, gripping, an carrying. Symptom Severity Scale (SSS): Scores range from 1-5, with higher scores indicating more severe symptoms Functional Status Scale (FSS): Scores range from 1-5, with higher scores indicating greater functional impairment .Reliability 0.95% and Validity 0.80%.

Interpretation

Symptom Severity Scale (SSS) Mild symptoms: 1-2 Moderate symptoms: 2-3 Severe symptoms: 3-4 Very severe symptoms: 4-5

Grip Strength12 Months

Digital Hand Dynamometer is a device used to measure grip strength, which is the force exerted by the hand when grasping an object. Hand Dynamometer units of measurement typically represents the maximum grip strength measured in units Kilograms (kg),Pounds (lb) And Newtons (N). Standard-range dynamometers: 0-100 kg (0-220 lb).

Normal Values for Grip Strength Adult Men: 35-55 kg Adult Women: 20-35 kg

Interpretation

Mild Weakness: 10-20% below normal range. Moderate Weakness: 20-40% below normal range. Severe Weakness: 40-60% below normal range. Profound Weakness: More than 60% below normal range."

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Superior University CRC

🇵🇰

Lahore, Punjab, Pakistan

© Copyright 2025. All Rights Reserved by MedPath